Primary infection with Epstein-Barr virus (EBV) and reactivation of latent virus are associated with increased antibody titers against the diffuse early antigen (EA-D). In order to better define the antigenic epitopes recognized by antibodies from patients with infectious mononucleosis (IM) and with
Expression of an early Epstein-Barr virus antigen (EA-D) in E. coli
✍ Scribed by Dagmar Roeckel; H. Boos; N. Mueller-Lantzsch
- Publisher
- Springer Vienna
- Year
- 1987
- Tongue
- English
- Weight
- 569 KB
- Volume
- 97
- Category
- Article
- ISSN
- 1432-8798
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The effect of two DNA antagonists (IUDR and Ara C) on EBV‐associated antigens was studied in two BL‐derived carrier culture lines (P3HR‐1 and Onesmas). Both drugs led to an accumulation of the early antigen (EA) from 2% in the untreated to 5–40% in the treated cultures. Ara C blocked th
## Abstract These data describe the use of a passive hemagglutination test (PHAT) for the detection of antibodies to the Epstein‐Barr virus (EBV) associated antigen, early antigen‐D (EA‐D). EA‐D was obtained from EBV‐superinfected RPMI 64–10 cell preparations which showed by immunofluorescent stain
## Abstract Epstein‐Barr virus (EBV) encoded DNA polymerase (POL) was cloned and over‐expressed in __Escherichia coli__. Western blot analysis confirmed the presence of antibody to this POL protein in sera from nasopharyngeal carcinoma (NPC) patients. By Western blot analysis, moderate to high conc
## Abstract Examination of numerous sera from patients with infectious mononucleodis (IM), Burkitt's lymphoma (BL) or nasopharyngeal carcinoma (NPC) for antibodieh to Epstein‐Barr virus (EBV) induced early antigens (EA) revealed two distinct patterns of immunofluorescence in abortively EBV‐infected